{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:12:38Z","timestamp":1794078758820,"version":"4.8.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jhep.2021.03.023","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T18:56:02Z","timestamp":1618599362000},"page":"324-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Towards personalised medicine in autoimmune hepatitis: Measurement of thiopurine metabolites results in higher biochemical response rates"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2170-992X","authenticated-orcid":false,"given":"Lena S.","family":"Candels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7733-8278","authenticated-orcid":false,"given":"Mussarat N.","family":"Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sital","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Heneghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jhep.2021.03.023_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2021.03.023_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/liv.13458","article-title":"Autoimmune hepatitis: from current knowledge and clinical practice to future research agenda","volume":"38","author":"Sebode","year":"2018","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.jhep.2021.03.023_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jceh.2017.01.115","article-title":"Role of allopurinol in optimizing thiopurine therapy in patients with autoimmune hepatitis: a review","volume":"7","author":"Deswal","year":"2017","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"9902","key":"10.1016\/j.jhep.2021.03.023_bib4","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","article-title":"Autoimmune hepatitis","volume":"382","author":"Heneghan","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jhep.2021.03.023_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4322\/acr.2017.021","article-title":"Histological remission of autoimmune hepatitis after the addition of allopurinol and azathioprine dose reduction","volume":"7","author":"Guedes","year":"2017","journal-title":"Autops Case Rep"},{"key":"10.1016\/j.jhep.2021.03.023_bib6","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","author":"Mack","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2021.03.023_bib7","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/hep.25760","article-title":"Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis","volume":"56","author":"Dhaliwal","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhep.2021.03.023_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/clpt.1989.119","article-title":"Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism","volume":"46","author":"Lennard","year":"1989","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jhep.2021.03.023_bib9","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.jhep.2021.03.023_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/jpet.104.074815","article-title":"Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines","volume":"312","author":"Thomas","year":"2005","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"4 Pt 2","key":"10.1016\/j.jhep.2021.03.023_bib11","first-page":"601","article-title":"Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase","volume":"29","author":"Weinshilboum","year":"2001","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.jhep.2021.03.023_bib12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.gastro.2015.08.040","article-title":"TPMT testing before starting azathioprine or mercaptopurine: surely just do it?","volume":"149","author":"Sanderson","year":"2015","journal-title":"Gastroenterology"},{"issue":"8907","key":"10.1016\/j.jhep.2021.03.023_bib13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0140-6736(94)92400-7","article-title":"Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia","volume":"343","author":"Lilleyman","year":"1994","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jhep.2021.03.023_bib14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2006.05.011","article-title":"Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis","volume":"45","author":"Heneghan","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"15","key":"10.1016\/j.jhep.2021.03.023_bib15","first-page":"958","article-title":"Azathioprine for long-term maintenance of remission in","volume":"333","author":"Johnson","year":"1995","journal-title":"Autoimmune Hepat"},{"issue":"1","key":"10.1016\/j.jhep.2021.03.023_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jhep.2009.10.004","article-title":"Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis","volume":"52","author":"Hindorf","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2021.03.023_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1155\/2011\/137476","article-title":"Azathioprine metabolite measurements are not useful in following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people","volume":"25","author":"Ferucci","year":"2011","journal-title":"Can J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jhep.2021.03.023_bib18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1053\/j.gastro.2006.01.046","article-title":"Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis","volume":"130","author":"Osterman","year":"2006","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jhep.2021.03.023_bib19","article-title":"Thiopurines' metabolites and drug toxicity: a meta-analysis","volume":"9","author":"Sousa","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"4","key":"10.1016\/j.jhep.2021.03.023_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"issue":"37","key":"10.1016\/j.jhep.2021.03.023_bib21","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.3748\/wjg.v17.i37.4166","article-title":"Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease","volume":"17","author":"Bradford","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhep.2021.03.023_bib22","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s10067-017-3554-4","article-title":"Metabolite monitoring to guide thiopurine therapy in systemic autoimmune diseases","volume":"36","author":"Chapdelaine","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.jhep.2021.03.023_bib23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/ibd\/izx081","article-title":"Late-onset rise of 6-MMP metabolites in IBD patients on azathioprine or mercaptopurine","volume":"24","author":"Munnig-Schmidt","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.jhep.2021.03.023_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2125.2010.03867.x","article-title":"Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy","volume":"71","author":"Adam de Beaumais","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jhep.2021.03.023_bib25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/apt.13879","article-title":"Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease","volume":"45","author":"Wong","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.jhep.2021.03.023_bib26","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/gut.2005.074930","article-title":"Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease","volume":"55","author":"Hindorf","year":"2006","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jhep.2021.03.023_bib27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2021.03.023_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2021.03.023_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/jhep.2002.30991","article-title":"Current and novel immunosuppressive therapy for autoimmune hepatitis","volume":"35","author":"Heneghan","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jhep.2021.03.023_bib30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/bjo.2006.092700","article-title":"Thiopurine methyltransferase screening before azathioprine therapy","volume":"90","author":"Gauba","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jhep.2021.03.023_bib31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/MPG.0000000000000455","article-title":"Thiopurine metabolite ratios for monitoring therapy in pediatric Crohn disease","volume":"59","author":"Kopylov","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.jhep.2021.03.023_bib32","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jhep.2012.09.002","article-title":"Treatment adherence - room for improvement, not only in autoimmune hepatitis","volume":"57","author":"Weiler-Normann","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2021.03.023_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/FTD.0b013e3181dbd712","article-title":"Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis","volume":"32","author":"Nguyen","year":"2010","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.jhep.2021.03.023_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MPG.0000000000001563","article-title":"Outcomes in pediatric autoimmune hepatitis and significance of azathioprine metabolites","volume":"65","author":"Sheiko","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.jhep.2021.03.023_bib35","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/hep.26198","article-title":"Use of a xanthine oxidase inhibitor in autoimmune hepatitis","volume":"57","author":"Al-Shamma","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2021.03.023_bib36","first-page":"391","article-title":"Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report","volume":"35","author":"Rumbo","year":"2002","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.jhep.2021.03.023_bib37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MIB.0000000000000197","article-title":"Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD","volume":"21","author":"Amin","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.jhep.2021.03.023_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/2040622315579063","article-title":"Optimizing the use of thiopurines in inflammatory bowel disease","volume":"6","author":"Goel","year":"2015","journal-title":"Ther Adv Chron Dis"},{"issue":"3","key":"10.1016\/j.jhep.2021.03.023_bib39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1445-5994.2012.02936.x","article-title":"Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease","volume":"43","author":"Kennedy","year":"2013","journal-title":"Intern Med J"},{"issue":"6","key":"10.1016\/j.jhep.2021.03.023_bib40","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/apt.12223","article-title":"Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis","volume":"37","author":"de Boer","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jhep.2021.03.023_bib41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0168-8278(02)00214-3","article-title":"Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis","volume":"37","author":"Langley","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2021.03.023_bib42","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s10620-006-9336-5","article-title":"Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis","volume":"51","author":"Czaja","year":"2006","journal-title":"Dig Dis Sci"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821002270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821002270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:43:09Z","timestamp":1759174989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827821002270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0168827821002270"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2021.03.023","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards personalised medicine in autoimmune hepatitis: Measurement of thiopurine metabolites results in higher biochemical response rates","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2021.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver. All rights reserved.","name":"copyright","label":"Copyright"}]}}